Molecular structural basis of ligand selectivity for 5-HT2 versus 5-HT1C cortical receptors

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Naunyn-Schmiedeberg's Archives of Pharmacology

• Publication date

  1992-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF00167563PMID 1407003
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex

  2004cited by this paper
• Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites

  2004cited by this paper
• Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens

  2004cited by this paper
• Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone

  2004cited by this paper
• Molecular Pharmacology

  2003cited by this paper
• Gaps and peculiarities in 5-HT2 receptor studies.

  1990cited by this paper
• 1-(m-chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain.

  1989cited by this paper
• Interaction of arylpiperazines with 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors: do discriminatory 5-HT1B receptor ligands exist?

  1989cited by this paper
• Hallucinogenic drug interactions at human brain 5-HT2 receptors: implications for treating LSD-induced hallucinogenesis

  1989cited by this paper
• Evidence for Distinct 5‐Hydroxytryptamine2 Binding Site Subtypes in Cortical Membrane Preparations

  1989cited by this paper
• Differentiation of 5-hydroxytryptamine2 receptor subtypes using 125I-R- (-)2,5-dimethoxy-4-iodo-phenylisopropylamine and 3H-ketanserin

  1989cited by this paper
• Three-dimensional steric molecular modeling of the 5-hydroxytryptamine3 receptor pharmacophore.

  1989cited by this paper
• The clinical utility of pharmacological agents that act at serotonin receptors.

  1989cited by this paper
• 5-HT1C receptor-mediated stimulation of inositol phosphate production in pig choroid plexus

  1989cited by this paper
• Comparison of [125I]Iodolysergic Acid Diethylamide Binding in Human Frontal Cortex and Platelet Tissue

  1989cited by this paper
• Structure and functional expression of cloned rat serotonin 5HT‐2 receptor.

  1988cited by this paper
• The dissociation rate of unlabelled drugs from receptor sites: a poorly investigated, yet important aspect in receptor research. Studies on the serotonin-S2 receptor.

  1988cited by this paper
• Functional correlates of serotonin 5-HT1 recognition sites.

  1988cited by this paper
• [3H]SCH 23390 labels both dopamine-1 and 5-hydroxytryptamine1c receptors in the choroid plexus.

  1988cited by this paper
• Indolealkylamine analogs share 5-HT2 binding characteristics with phenylalkylamine hallucinogens.

  1988cited by this paper
• Graphics computer-aided receptor mapping as a predictive tool for drug design: development of potent, selective, and stereospecific ligands for the 5-HT1A receptor.

  1988cited by this paper
• [125I]SCH 23982, a 'selective' D-1 receptor antagonist, labels with high affinity 5-HT1C sites in pig choroid plexus.

  1988cited by this paper
• In vitro studies with ICI 169,369, a chemically novel 5-HT antagonist.

  1988cited by this paper
• Putative selective 5-HT-2 antagonists block serotonin 5-HT-1c receptors in the choroid plexus.

  1988cited by this paper
• Molecular characterization of a functional cDNA encoding the serotonin 1c receptor.

  1988cited by this paper
• Pharmacological effects of MDL 11,939: A selective, centrally acting antagonist of 5‐HT2 receptors

  1988cited by this paper
• Effect of 5-hydroxytryptamine on the rate of cerebrospinal fluid production in rabbit.

  1988cited by this paper
• Antimigraine drug interactions with serotonin receptor subtypes in human brain

  1988cited by this paper
• Molecular pharmacology and biology of 5-HT1C receptors.

  1988cited by this paper
• Molecular determinants for recognition of RU 24969 analogs at central 5-hydroxytryptamine recognition sites: use of a bilinear function and substituent volumes to describe steric fit.

  1988cited by this paper
• Chimeric alpha 2-,beta 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity.

  1988cited by this paper
• Identification of the serotonin‐S2 receptor ligand binding site by photoaffinity labelling with 7‐azido‐8‐[125I]ketanserin ([125I]AZIK)

  1987cited by this paper
• Antagonism by neuroleptics of serotonin 5-HT1A and 5-HT2 receptors of normal human brain in vitro.

  1987cited by this paper
• 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.

  1987cited by this paper
• Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5-HT-1c) receptors.

  1987cited by this paper
• N1‐Methyl‐2‐125I‐Lysergic Acid Diethylamide, a Preferred Ligand for In Vitro and In Vivo Characterization of Serotonin Receptors

  1987cited by this paper
• Cardiovascular Response to 8-Hydroxy-2-(di-n-Propylamino) Tetralin (8-OH-DPAT) in the Rat: Site of Action and Pharmacological Analysis

  1987cited by this paper
• Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.

  1987cited by this paper
• Biochemical and pharmacological characterization of CGS 12066B, a selective serotonin-1B agonist.

  1987cited by this paper
• [3H]ketanserin labels serotonin 5-HT2 and alpha 1-adrenergic receptors in human brain cortex.

  1987cited by this paper
• Characterization of Two [3H]Ketanserin Recognition Sites in Rat Striatum

  1987cited by this paper
• 5-HT1 and 5-HT2 binding characteristics of some quipazine analogues.

  1986cited by this paper
• Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites.

  1986cited by this paper
• 5-Hydroxytryptamine2 receptors coupled to phospholipase C in rat aorta: modulation of phosphoinositide turnover by phorbol ester.

  1986cited by this paper
• Pharmacological analysis of the behavioural and thermoregulatory effects of the putative 5-HT1 receptor agonist, RU 24969, in the rat.

  1986cited by this paper
• A common structural model for central nervous system drugs and their receptors.

  1986cited by this paper
• Serotonin 5-HT1C receptors are expressed at high density on choroid plexus tumors from transgenic mice.

  1986cited by this paper
• A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover.

  1986cited by this paper
• Serotonin increases the production of inositol phosphates and mobilises calcium via the 5-HT2 receptor in A7r5 smooth muscle cells

  1986cited by this paper
• 3H-3-N-methylspiperone labels D2 dopamine receptors in basal ganglia and S2 serotonin receptors in cerebral cortex

  1986cited by this paper
• 1-(1-Naphthyl)piperazine, a central serotonin agonist.

  1986cited by this paper
• 5-HT1A-receptors mediate stimulation of adenylate cyclase in rat hippocampus

  1986cited by this paper
• Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites.

  1986cited by this paper
• Binding of the putative anxiolytic TVX Q 7821 to hippocampal 5-hydroxytryptamine (5-HT) recognition sites

  1985cited by this paper
• 5-Hydroxytryptamine-stimulated inositol phospholipid hydrolysis in rat cerebral cortex slices: pharmacological characterization and effects of antidepressants.

  1985cited by this paper
• Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptors.

  1985cited by this paper
• [(125)I]LSD binding to serotonin and dopamine receptors in bovine caudate membranes.

  1985cited by this paper
• Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.

  1985cited by this paper
• Characterization of 125I‐Lysergic Acid Diethylamide Binding to Serotonin Receptors in Rat Frontal Cortex

  1984cited by this paper
• Guanyl Nucleotide and Divalent Cation Regulation of Cortical S2 Serotonin Receptors

  1984cited by this paper
• Selective 5HT-2 antagonists inhibit serotonin stimulated phosphatidylinositol metabolism in cerebral cortex.

  1984cited by this paper
• Mesulergine, a selective serotonin-2 ligand in the rat cortex, does not label these receptors in porcine and human cortex: evidence for species differences in brain serotonin-2 receptors.

  1984cited by this paper
• The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site.

  1984cited by this paper
• Guanine nucleotides modulate cortical S2 serotonin receptors.

  1984cited by this paper
• Specific [3H]-spiroperidol binding sites in human prefrontal cortex: potential site multiplicity and overall serotonin-like selectivity.

  1984cited by this paper
• 125I-LSD: a high sensitivity ligand for serotonin receptors.

  1983cited by this paper
• [3H]Mesulergine, a selective ligand for serotonin-2 receptors.

  1983cited by this paper
• pH-dependent modulation of agonist interactions with [3H]-ketanserin-labelled S2 serotonin receptors.

  1983cited by this paper
• [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role.

  1982cited by this paper
• Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency.

  1980cited by this paper
• Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol.

  1979cited by this paper
• 3H-Spiroperidol labels serotonin receptors in rat cerebral cortex and hippocampus.

  1978cited by this paper
• A serotonergic component of neuroleptic receptors.

  1977cited by this paper
• Autonomic correlates of the photically activated EEG.

  1960cited by this paper

• Depression of mGluR‐mediated IPSCs by 5‐HT in dopamine neurons of the rat substantia nigra pars compacta

  2003cites this paper
• 5-HT2A and 5-HT2C/5-HT1B receptors are differentially involved in alcohol preference and consummatory behavior in cAA rats.

  1999cites this paper
• Facilitation of female rat lordosis behavior by hypothalamic infusion of 5-HT(2A/2C) receptor agonists.

  1998cites this paper
• 5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): where structure meets function.

  1998cites this paper
• Auditory-evoked potentials as indicator of brain serotonergic activity--first evidence in behaving cats.

  1997cites this paper
• Involvement of 5-hydroxytryptamine 2A (5-HT2A) receptors in the mediation of the discriminative stimulus properties of (+/-)DOI in rats.

  1997cites this paper
• Dual role of 5-HT in defense and anxiety.

  1997cites this paper
• Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives.

  1997cites this paper
• Molecular modeling of serotonin, ketanserin, ritanserin and their 5-HT2C receptor interactions.

  1996cites this paper
• The effects of paroxetine given repeatedly on the 5-HT receptor subpopulations in the rat brain

  1996cites this paper
• Activities of novel aryloxyalkylimidazolines on rat 5-HT2A and 5-HT2C receptors.

  1996cites this paper
• Chronic Administration of Serotonergic Antidepressants Attenuates the Subjective Effects of LSD in Humans

  1996cites this paper
• Further evidence that fluoxetine interacts with a 5-HT2C receptor in glial cells.

  1995cites this paper
• Behavioural interactions between 5‐hydroxytryptophan, neuroleptic agents and 5‐HT receptor antagonists in modifying rodent responding to aversive situations

  1995cites this paper
• Role of 5-HT receptor subtypes in the modulation of dorsal periaqueductal gray generated aversion.

  1995cites this paper
• 5-Hydroxytryptamine2 receptor-mediated regulation of periventricular-hypophysial dopaminergic neuronal activity and the secretion of alpha-melanocyte-stimulating hormone.

  1994cites this paper
• The head-twitch response in the least shrew (Cryptotis parva) is a 5-HT2- and not a 5-HT1C-mediated phenomenon.

  1994cites this paper
• Drug discrimination and receptor binding studies of N-isopropyl lysergamide derivatives.

  1994cites this paper
• 5HT2 receptors mediate the effects of stress on the activity of periventricular hypophysial dopaminergic neurons and the secretion of alpha-melanocyte-stimulating hormone.

  1993cites this paper
• Stereospecific and selective 5-HT2 antagonism in a series of 5-substituted trans-1-piperazino-3-phenylindans.

  1993cites this paper